Macrotech Developers Limited (LODHA.NS)
INR 1122.6
(1.02%)
INR 1122.6
(1.02%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 103.16 Billion | 94.7 Billion | 91.46 Billion | 53.53 Billion | 122.25 Billion | 117.99 Billion |
| Cost of Revenue | 62.02 Billion | 60.64 Billion | 60.62 Billion | 36.03 Billion | 95.49 Billion | 73.77 Billion |
| Gross Profit | 41.13 Billion | 34.06 Billion | 30.84 Billion | 17.49 Billion | 26.75 Billion | 44.21 Billion |
| Operating Expenses | 8.9 Billion | 14.33 Billion | -1 Billion | 6.05 Billion | 9.43 Billion | 13.88 Billion |
| Selling, General and Administrative Expenses | 8.9 Billion | 2.56 Billion | 1.7 Billion | 1.27 Billion | 4.16 Billion | 8.57 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 1.4 Billion | 5.1 Million | 46.2 Million | 278.48 Million | 245.77 Million |
| Cost and Expenses | 72.23 Billion | 74.97 Billion | 59.62 Billion | 42.08 Billion | 104.93 Billion | 87.66 Billion |
| Operating Income | 30.92 Billion | 19.81 Billion | 21.12 Billion | 11.27 Billion | 16.91 Billion | 30.32 Billion |
| Interest Expense | 4.81 Billion | 4.79 Billion | 19.34 Billion | 24.76 Billion | 7.31 Billion | 5.55 Billion |
| Income Tax Expense | 4.73 Billion | -370 Million | 5.08 Billion | -147.3 Million | 2.61 Billion | 8.44 Billion |
| Earnings before Tax | 20.27 Billion | 4.52 Billion | 17.16 Billion | 331.6 Million | 10.06 Billion | 24.88 Billion |
| Net Income | 15.49 Billion | 4.86 Billion | 12.02 Billion | 401.6 Million | 7.3 Billion | 16.36 Billion |
| Earnings Per Share Basic | 16.03 | 5.05 | 13.14 | 0.51 | 9.19 | 18.29 |
| Earnings Per Share Diluted | 15.99 | 5.05 | 13.12 | 0.51 | 9.19 | 18.29 |
| Weighted Average Shares Outstanding | 966.37 Million | 963.31 Million | 915.04 Million | 826.75 Million | 826.75 Million | 894.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 968.95 Million | 964.55 Million | 916.17 Million | 826.75 Million | 826.75 Million | 894.63 Million |
| Gross Margin | 0.40 | 0.36 | 0.34 | 0.33 | 0.22 | 0.37 |
| EBIT Margin | 0.26 | 0.23 | 0.52 | 0.57 | 0.17 | 0.27 |
| Profit Margin | 0.15 | 0.05 | 0.13 | 0.01 | 0.06 | 0.14 |
| EBITDA | 27.26 Billion | 10.32 Billion | 24.78 Billion | 12.43 Billion | 19.6 Billion | 31.94 Billion |
| Earnings Before Tax Margin | 0.30 | 0.21 | 0.23 | 0.21 | 0.14 | 0.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 26.25 Billion | 28.46 Billion | 40.18 Billion | 103.16 Billion | 29.3 Billion | 17.49 Billion |
| Cost of Revenue | 15.72 Billion | 19.11 Billion | 27.59 Billion | 68.77 Billion | 16.77 Billion | 9.99 Billion |
| Gross Profit | 10.53 Billion | 9.35 Billion | 12.59 Billion | 34.38 Billion | 12.53 Billion | 7.5 Billion |
| Operating Expenses | 4.15 Billion | 2.38 Billion | 3.29 Billion | 9.66 Billion | 4.03 Billion | 3.63 Billion |
| Selling, General and Administrative Expenses | 2.08 Billion | 2.38 Billion | 3.29 Billion | - | 2.53 Billion | 2.19 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 4.15 Billion | 718 Million | 654 Million | 1.53 Billion | 281 Million | 55 Million |
| Cost and Expenses | 19.87 Billion | 21.5 Billion | 30.88 Billion | 78.44 Billion | 20.81 Billion | 13.62 Billion |
| Operating Income | 6.38 Billion | 6.96 Billion | 9.29 Billion | 24.71 Billion | 8.7 Billion | 3.88 Billion |
| Interest Expense | 1.36 Billion | 1.17 Billion | 1.15 Billion | 4.79 Billion | 1.16 Billion | 1.23 Billion |
| Income Tax Expense | 1.36 Billion | 1.74 Billion | 2.11 Billion | 4.73 Billion | 1.43 Billion | 624 Million |
| Earnings before Tax | 5.59 Billion | 6.51 Billion | 8.79 Billion | 20.4 Billion | 6.49 Billion | 2.65 Billion |
| Net Income | 4.22 Billion | 4.75 Billion | 6.65 Billion | 15.49 Billion | 5.03 Billion | 2.01 Billion |
| Earnings Per Share Basic | 4.25 | 4.78 | 6.84 | - | 5.22 | 2.09 |
| Earnings Per Share Diluted | 4.23 | 4.76 | 6.81 | - | 5.20 | 2.09 |
| Weighted Average Shares Outstanding | 995.05 Million | 994.94 Million | 977.23 Million | 966.37 Million | 964.46 Million | 964.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 999.76 Million | 998.52 Million | 977.23 Million | 968.79 Million | 967.88 Million | 964.37 Million |
| Gross Margin | 0.40 | 0.33 | 0.31 | 0.33 | 0.43 | 0.43 |
| EBIT Margin | 0.29 | 0.27 | 0.26 | - | 0.31 | 0.24 |
| Profit Margin | 0.16 | 0.17 | 0.17 | 0.15 | 0.17 | 0.12 |
| EBITDA | 7.62 Billion | 7.56 Billion | 10.46 Billion | - | 9.04 Billion | 4.17 Billion |
| Earnings Before Tax Margin | 0.24 | 0.24 | 0.23 | 0.24 | 0.30 | 0.22 |
CME
AMBUJACEM
6496
9744
PFIZER
OCT